Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Eolus Vind B | 7EVB | Nov 22, 2024 | 3.94 | -0.63 |
EPAM Systems, Inc. | E3M | Nov 22, 2024 | 234.80 | +0.64 |
EPE Special Opportunities Limited | EP0 | Nov 22, 2024 | 1.81 | -1.63 |
EPENDION AB SK 0,3333 | TW4 | Nov 22, 2024 | 8.03 | +1.13 |
Epigenomics AG | ECX | Nov 22, 2024 | 1.20 | +20.00 |
Epiroc A | 3AD1 | Nov 22, 2024 | 16.81 | +0.39 |
EPIROC AB UNSP.ADR/1 | 3ADA | Nov 22, 2024 | 16.40 | 0.00 |
Epiroc B | 3AD2 | Nov 22, 2024 | 15.20 | +0.13 |
Episurf Medical B | 16E | Nov 22, 2024 | 0.00 | -3.23 |
ePlay Digital Inc | 2NY2 | Nov 22, 2024 | 0.00 | 0.00 |
ePlus inc. | MLE | Nov 22, 2024 | 76.00 | -0.65 |
EPR Properties | E2H | Nov 22, 2024 | 42.79 | +2.38 |
EPRCOMUNICAZIONE S.P.A. | J3P | Nov 22, 2024 | 1.05 | -0.94 |
EPTI AB AK | G7H0 | Nov 22, 2024 | 1.71 | 0.00 |
Epwin Group Plc | 2E3 | Nov 22, 2024 | 1.22 | 0.00 |
EQB INC. | V22 | Nov 22, 2024 | 74.50 | +1.36 |
EQL Pharma | 7JK | Nov 22, 2024 | 5.74 | +2.50 |
EQT | 6EQ | Nov 22, 2024 | 26.35 | +4.23 |
EQT Corporation | EQ6 | Nov 22, 2024 | 45.24 | -0.12 |
Eqtec | KEU | Nov 22, 2024 | 0.01 | 0.00 |
Equals Group Plc | 2FX | Nov 22, 2024 | 1.39 | -0.71 |
Equatorial Resources Limited | PBU | Nov 22, 2024 | 0.06 | +2.75 |
Equifax, Inc. | EFX | Nov 22, 2024 | 240.00 | +2.56 |
Equillium, Inc. | 0FY | Nov 22, 2024 | 0.66 | +4.26 |
Equinix, Inc. | EQN2 | Nov 22, 2024 | 899.00 | +3.69 |
Equinor | DNQ | Nov 22, 2024 | 23.59 | -1.52 |
Equinor ASA | DNQA | Nov 22, 2024 | 23.50 | -0.42 |
Equinox Gold Corp | 1LRC | Nov 22, 2024 | 5.49 | +3.00 |
EQUIPMAKE HLDGS LS -,0001 | U8O | Nov 22, 2024 | 0.03 | 0.00 |
Equitable Holdings Inc | AXJ | Nov 22, 2024 | 44.00 | +0.92 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.